Skip to content

5-Amino-1MQ

NNMT Inhibitor. Small molecule NNMT (nicotinamide N-methyltransferase) inhibitor. Blocks NNMT to elevate NAD+ and SAM, improve mitochondrial function, and reduce fat cell activity. Metabolic health, fat loss, NAD+ elevation.

Intelligence Profile

Clinical Applications

Clinical Applications

Currently, there are no published clinical trials or peer-reviewed studies available for 5-Amino-1MQ in medical databases. Without clinical evidence from human studies, the therapeutic applications, safety profile, and efficacy of this compound remain unestablished from a scientific perspective.

The absence of clinical data means there are no validated medical uses for 5-Amino-1MQ, and any purported benefits or applications cannot be substantiated by rigorous scientific evidence. Healthcare providers and patients should be aware that compounds lacking clinical validation may pose unknown risks and have unproven therapeutic value.

Disclaimer: This information is for educational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before considering any therapeutic interventions.

Free account required

Clinical data requires a free AXIFI account to access clinical data, safety profiles, and research papers.